162 related articles for article (PubMed ID: 7562053)
1. Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide.
Scott GC; Meier DA; Dickinson CZ
J Nucl Med; 1995 Oct; 36(10):1843-5. PubMed ID: 7562053
[TBL] [Abstract][Full Text] [Related]
2. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
3. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer.
Feine U; Lietzenmayer R; Hanke JP; Held J; Wöhrle H; Müller-Schauenburg W
J Nucl Med; 1996 Sep; 37(9):1468-72. PubMed ID: 8790195
[TBL] [Abstract][Full Text] [Related]
4. Detecting metastatic neck lymph nodes in papillary thyroid carcinoma by 18F-2-deoxyglucose positron emission tomography and Tc-99m tetrofosmin single photon emission computed tomography.
Wu YJ; Wu HS; Yen RF; Shen YY; Kao CH
Anticancer Res; 2003; 23(3C):2973-6. PubMed ID: 12926147
[TBL] [Abstract][Full Text] [Related]
5. Comparison of F-18 FDG to I-123 and I-131 scans in thyroid carcinoma.
Bakheet SM; Powe JE; Hammami MM; Ahmed M
Clin Nucl Med; 1997 Jun; 22(6):438-9. PubMed ID: 9193832
[No Abstract] [Full Text] [Related]
6. Early changes in fluorine-18-FDG uptake during radiotherapy.
Hautzel H; Müller-Gärtner HW
J Nucl Med; 1997 Sep; 38(9):1384-6. PubMed ID: 9293793
[TBL] [Abstract][Full Text] [Related]
7. I-131, I-123, and F-18 FDG-PET imaging in a patient with diffuse sclerosing variant of papillary thyroid cancer.
Wong TZ; Jain MK; Spratt SE
Clin Nucl Med; 2008 Dec; 33(12):834-7. PubMed ID: 19033781
[TBL] [Abstract][Full Text] [Related]
8. Whole-body scintigraphy with 99Tcm-MIBI, 18F-FDG and 131I in patients with metastatic thyroid carcinoma.
Fridrich L; Messa C; Landoni C; Lucignani G; Moncayo R; Kendler D; Riccabona G; Fazio F
Nucl Med Commun; 1997 Jan; 18(1):3-9. PubMed ID: 9061694
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m-furifosmin in the follow-up of differentiated thyroid carcinoma.
Brandt-Mainz K; Müller SP; Sonnenschein W; Bockisch A
J Nucl Med; 1998 Sep; 39(9):1536-41. PubMed ID: 9744338
[TBL] [Abstract][Full Text] [Related]
10. Imaging of metastases of thyroid carcinoma with fluorine-18 fluorodeoxyglucose.
Joensuu H; Ahonen A
J Nucl Med; 1987 May; 28(5):910-4. PubMed ID: 3572549
[TBL] [Abstract][Full Text] [Related]
11. [PET-FDG in thyroid cancer with high thyroglobulin levels and negative 131-I scan. A case report].
Ortega F; Maldonado A; Marañes P; Montz R; Pérez-Castejón MJ; Melgarejo M; Ruiz JA; Carreras JL
Rev Esp Med Nucl; 1999; 18(1):50-4. PubMed ID: 10074219
[TBL] [Abstract][Full Text] [Related]
12. Insensitivity of Tc-99m pertechnetate for detecting metastases of differentiated thyroid carcinoma.
Campbell CM; Khafagi FA
Clin Nucl Med; 1990 Jan; 15(1):1-4. PubMed ID: 2155079
[TBL] [Abstract][Full Text] [Related]
13. [18FDG whole-body PET in differentiated thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 131I].
Feine U; Lietzenmayer R; Hanke JP; Wöhrle H; Müller-Schauenburg W
Nuklearmedizin; 1995 Aug; 34(4):127-34. PubMed ID: 7675641
[TBL] [Abstract][Full Text] [Related]
14. Preoperative scintigraphic visualization of lymph nodes and pulmonary metastases from papillary thyroid carcinoma.
Boughattas S; Hassine H; Arifa N; Chatti K; Degdegui M; Abdelkefi M; Essabbah H
Ann Nucl Med; 2004 Feb; 18(1):59-62. PubMed ID: 15072185
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of suspected recurrent papillary thyroid carcinoma with [18F]fluorodeoxyglucose positron emission tomography.
Jadvar H; McDougall IR; Segall GM
Nucl Med Commun; 1998 Jun; 19(6):547-54. PubMed ID: 10234658
[TBL] [Abstract][Full Text] [Related]
16. Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: implications for diagnosis and therapy.
Sisson JC; Ackermann RJ; Meyer MA; Wahl RL
J Clin Endocrinol Metab; 1993 Oct; 77(4):1090-4. PubMed ID: 8408458
[TBL] [Abstract][Full Text] [Related]
17. Metastatic thyroid cancer visualized on technetium pertechnetate and iodine-131 scintigraphy.
Verma N; Singh-Wadhwa S; Arvela OM
Clin Nucl Med; 2002 Aug; 27(8):610. PubMed ID: 12170017
[No Abstract] [Full Text] [Related]
18. Metastatic pure papillary thyroid carcinoma presenting as a toxic hot nodule.
Cirillo RL; Pozderac RV; Caniano DA; Falko JM
Clin Nucl Med; 1998 Jun; 23(6):345-9. PubMed ID: 9619317
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of (99m)Tc-pertechnetate whole body scan with neck and chest SPECT/CT for detection of post-surgical thyroid remnant and metastasis in differentiated thyroid cancer patients.
Chantadisai M; Kingpetch K
Ann Nucl Med; 2014 Aug; 28(7):674-82. PubMed ID: 24889127
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and benefit of fluorine 18-fluoro-2-deoxyglucose-guided surgery in the management of radioiodine-negative differentiated thyroid carcinoma metastases.
Kraeber-Bodéré F; Cariou B; Curtet C; Bridji B; Rousseau C; Dravet F; Charbonnel B; Carnaille B; Le Néel JC; Mirallié E
Surgery; 2005 Dec; 138(6):1176-82; discussion 1182. PubMed ID: 16360406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
